Global Opioid-Induced Constipation Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Global Opioid-Induced Constipation Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Table of Contents
1 Study Coverage
1.1 Opioid-Induced Constipation Product Introduction
1.2 Market by Type
1.2.1 Global Opioid-Induced Constipation Market Size Growth Rate by Type
1.2.2 Methylnaltrexone Bromide
1.2.3 Lubiprostone
1.2.4 Naloxegol
1.2.5 Others
1.3 Market by Application
1.3.1 Global Opioid-Induced Constipation Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Opioid-Induced Constipation Market Size Estimates and Forecasts
2.1.1 Global Opioid-Induced Constipation Revenue 2015-2026
2.1.2 Global Opioid-Induced Constipation Sales 2015-2026
2.2 Opioid-Induced Constipation Market Size by Region: 2020 Versus 2026
2.3 Opioid-Induced Constipation Sales by Region (2015-2026)
2.3.1 Global Opioid-Induced Constipation Sales by Region: 2015-2020
2.3.2 Global Opioid-Induced Constipation Sales Forecast by Region (2021-2026)
2.3.3 Global Opioid-Induced Constipation Sales Market Share by Region (2015-2026)
2.4 Opioid-Induced Constipation Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Opioid-Induced Constipation Revenue by Region: 2015-2020
2.4.2 Global Opioid-Induced Constipation Revenue Forecast by Region (2021-2026)
2.4.3 Global Opioid-Induced Constipation Revenue Market Share by Region (2015-2026)
3 Global Opioid-Induced Constipation by Manufacturers
3.1 Global Top Opioid-Induced Constipation Manufacturers by Sales
3.1.1 Global Opioid-Induced Constipation Sales by Manufacturer (2015-2020)
3.1.2 Global Opioid-Induced Constipation Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Opioid-Induced Constipation Manufacturers by Revenue
3.2.1 Global Opioid-Induced Constipation Revenue by Manufacturer (2015-2020)
3.2.2 Global Opioid-Induced Constipation Revenue Share by Manufacturer (2015-2020)
3.3 Global Opioid-Induced Constipation Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Opioid-Induced Constipation Manufacturers Covered: Ranking by Revenue
3.4.2 Global Opioid-Induced Constipation Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Opioid-Induced Constipation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Opioid-Induced Constipation Manufacturing Base Distribution, Product Type
3.5.1 Opioid-Induced Constipation Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Opioid-Induced Constipation Product Type
3.5.3 Date of International Manufacturers Enter into Opioid-Induced Constipation Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Takeda Pharmaceuticals
4.1.1 Takeda Pharmaceuticals Corporation Information
4.1.2 Takeda Pharmaceuticals Description, Business Overview
4.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Products Offered
4.1.4 Takeda Pharmaceuticals Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Takeda Pharmaceuticals Opioid-Induced Constipation Revenue by Product
4.1.6 Takeda Pharmaceuticals Opioid-Induced Constipation Revenue by Application
4.1.7 Takeda Pharmaceuticals Opioid-Induced Constipation Revenue by Geographic Area
4.1.8 Takeda Pharmaceuticals Opioid-Induced Constipation Revenue by Sales Channel
4.1.9 Takeda Pharmaceuticals Recent Development
4.2 Bayer
4.2.1 Bayer Corporation Information
4.2.2 Bayer Description, Business Overview
4.2.3 Bayer Opioid-Induced Constipation Products Offered
4.2.4 Bayer Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Bayer Opioid-Induced Constipation Revenue by Product
4.2.6 Bayer Opioid-Induced Constipation Revenue by Application
4.2.7 Bayer Opioid-Induced Constipation Revenue by Geographic Area
4.2.8 Bayer Opioid-Induced Constipation Revenue by Sales Channel
4.2.9 Bayer Recent Development
4.3 Sanofi
4.3.1 Sanofi Corporation Information
4.3.2 Sanofi Description, Business Overview
4.3.3 Sanofi Opioid-Induced Constipation Products Offered
4.3.4 Sanofi Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.3.5 Sanofi Opioid-Induced Constipation Revenue by Product
4.3.6 Sanofi Opioid-Induced Constipation Revenue by Application
4.3.7 Sanofi Opioid-Induced Constipation Revenue by Geographic Area
4.3.8 Sanofi Opioid-Induced Constipation Revenue by Sales Channel
4.3.9 Sanofi Recent Development
4.4 Mallinckrodt
4.4.1 Mallinckrodt Corporation Information
4.4.2 Mallinckrodt Description, Business Overview
4.4.3 Mallinckrodt Opioid-Induced Constipation Products Offered
4.4.4 Mallinckrodt Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Mallinckrodt Opioid-Induced Constipation Revenue by Product
4.4.6 Mallinckrodt Opioid-Induced Constipation Revenue by Application
4.4.7 Mallinckrodt Opioid-Induced Constipation Revenue by Geographic Area
4.4.8 Mallinckrodt Opioid-Induced Constipation Revenue by Sales Channel
4.4.9 Mallinckrodt Recent Development
4.5 Salix (Bausch Health)
4.5.1 Salix (Bausch Health) Corporation Information
4.5.2 Salix (Bausch Health) Description, Business Overview
4.5.3 Salix (Bausch Health) Opioid-Induced Constipation Products Offered
4.5.4 Salix (Bausch Health) Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Salix (Bausch Health) Opioid-Induced Constipation Revenue by Product
4.5.6 Salix (Bausch Health) Opioid-Induced Constipation Revenue by Application
4.5.7 Salix (Bausch Health) Opioid-Induced Constipation Revenue by Geographic Area
4.5.8 Salix (Bausch Health) Opioid-Induced Constipation Revenue by Sales Channel
4.5.9 Salix (Bausch Health) Recent Development
4.6 AstraZeneca
4.6.1 AstraZeneca Corporation Information
4.6.2 AstraZeneca Description, Business Overview
4.6.3 AstraZeneca Opioid-Induced Constipation Products Offered
4.6.4 AstraZeneca Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.6.5 AstraZeneca Opioid-Induced Constipation Revenue by Product
4.6.6 AstraZeneca Opioid-Induced Constipation Revenue by Application
4.6.7 AstraZeneca Opioid-Induced Constipation Revenue by Geographic Area
4.6.8 AstraZeneca Recent Development
4.7 Progenics Pharmaceuticals
4.7.1 Progenics Pharmaceuticals Corporation Information
4.7.2 Progenics Pharmaceuticals Description, Business Overview
4.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Products Offered
4.7.4 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.7.5 Progenics Pharmaceuticals Opioid-Induced Constipation Revenue by Product
4.7.6 Progenics Pharmaceuticals Opioid-Induced Constipation Revenue by Application
4.7.7 Progenics Pharmaceuticals Opioid-Induced Constipation Revenue by Geographic Area
4.7.8 Progenics Pharmaceuticals Recent Development
4.8 Purdue Pharm
4.8.1 Purdue Pharm Corporation Information
4.8.2 Purdue Pharm Description, Business Overview
4.8.3 Purdue Pharm Opioid-Induced Constipation Products Offered
4.8.4 Purdue Pharm Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.8.5 Purdue Pharm Opioid-Induced Constipation Revenue by Product
4.8.6 Purdue Pharm Opioid-Induced Constipation Revenue by Application
4.8.7 Purdue Pharm Opioid-Induced Constipation Revenue by Geographic Area
4.8.8 Purdue Pharm Recent Development
4.9 Nektar Therapeutics
4.9.1 Nektar Therapeutics Corporation Information
4.9.2 Nektar Therapeutics Description, Business Overview
4.9.3 Nektar Therapeutics Opioid-Induced Constipation Products Offered
4.9.4 Nektar Therapeutics Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.9.5 Nektar Therapeutics Opioid-Induced Constipation Revenue by Product
4.9.6 Nektar Therapeutics Opioid-Induced Constipation Revenue by Application
4.9.7 Nektar Therapeutics Opioid-Induced Constipation Revenue by Geographic Area
4.9.8 Nektar Therapeutics Recent Development
4.10 Daiichi Sankyo
4.10.1 Daiichi Sankyo Corporation Information
4.10.2 Daiichi Sankyo Description, Business Overview
4.10.3 Daiichi Sankyo Opioid-Induced Constipation Products Offered
4.10.4 Daiichi Sankyo Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.10.5 Daiichi Sankyo Opioid-Induced Constipation Revenue by Product
4.10.6 Daiichi Sankyo Opioid-Induced Constipation Revenue by Application
4.10.7 Daiichi Sankyo Opioid-Induced Constipation Revenue by Geographic Area
4.10.8 Daiichi Sankyo Recent Development
4.11 Prestige
4.11.1 Prestige Corporation Information
4.11.2 Prestige Description, Business Overview
4.11.3 Prestige Opioid-Induced Constipation Products Offered
4.11.4 Prestige Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.11.5 Prestige Opioid-Induced Constipation Revenue by Product
4.11.6 Prestige Opioid-Induced Constipation Revenue by Application
4.11.7 Prestige Opioid-Induced Constipation Revenue by Geographic Area
4.11.8 Prestige Recent Development
4.12 GSK
4.12.1 GSK Corporation Information
4.12.2 GSK Description, Business Overview
4.12.3 GSK Opioid-Induced Constipation Products Offered
4.12.4 GSK Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.12.5 GSK Opioid-Induced Constipation Revenue by Product
4.12.6 GSK Opioid-Induced Constipation Revenue by Application
4.12.7 GSK Opioid-Induced Constipation Revenue by Geographic Area
4.12.8 GSK Recent Development
4.13 Shionogi
4.13.1 Shionogi Corporation Information
4.13.2 Shionogi Description, Business Overview
4.13.3 Shionogi Opioid-Induced Constipation Products Offered
4.13.4 Shionogi Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.13.5 Shionogi Opioid-Induced Constipation Revenue by Product
4.13.6 Shionogi Opioid-Induced Constipation Revenue by Application
4.13.7 Shionogi Opioid-Induced Constipation Revenue by Geographic Area
4.13.8 Shionogi Recent Development
5 Breakdown Data by Type
5.1 Global Opioid-Induced Constipation Sales by Type (2015-2026)
5.1.1 Global Opioid-Induced Constipation Sales by Type (2015-2020)
5.1.2 Global Opioid-Induced Constipation Sales Forecast by Type (2021-2026)
5.1.3 Global Opioid-Induced Constipation Sales Market Share by Type (2015-2026)
5.2 Global Opioid-Induced Constipation Revenue Forecast by Type (2015-2026)
5.2.1 Global Opioid-Induced Constipation Revenue by Type (2015-2020)
5.2.2 Global Opioid-Induced Constipation Revenue Forecast by Type (2021-2026)
5.2.3 Global Opioid-Induced Constipation Revenue Market Share by Type (2015-2026)
5.3 Opioid-Induced Constipation Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Opioid-Induced Constipation Sales by Application (2015-2026)
6.1.1 Global Opioid-Induced Constipation Sales by Application (2015-2020)
6.1.2 Global Opioid-Induced Constipation Sales Forecast by Application (2021-2026)
6.1.3 Global Opioid-Induced Constipation Sales Market Share by Application (2015-2026)
6.2 Global Opioid-Induced Constipation Revenue Forecast by Application (2015-2026)
6.2.1 Global Opioid-Induced Constipation Revenue by Application (2015-2020)
6.2.2 Global Opioid-Induced Constipation Revenue Forecast by Application (2021-2026)
6.2.3 Global Opioid-Induced Constipation Revenue Market Share by Application (2015-2026)
6.3 Opioid-Induced Constipation Average Selling Price (ASP) by Application (2015-2026)
7 North America
7.1 North America Opioid-Induced Constipation Market Size YoY Growth 2015-2026
7.2 North America Opioid-Induced Constipation Market Facts & Figures by Country
7.2.1 North America Opioid-Induced Constipation Sales by Country (2015-2026)
7.2.2 North America Opioid-Induced Constipation Revenue by Country (2015-2026)
7.3 North America Opioid-Induced Constipation Sales by Type
7.4 North America Opioid-Induced Constipation Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Opioid-Induced Constipation Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Opioid-Induced Constipation Market Facts & Figures by Region
8.2.1 Asia-Pacific Opioid-Induced Constipation Sales by Region (2015-2026)
8.2.2 Asia-Pacific Opioid-Induced Constipation Revenue by Region (2015-2026)
8.3 Asia-Pacific Opioid-Induced Constipation Sales by Type
8.4 Asia-Pacific Opioid-Induced Constipation Sales by Application
9 Europe
9.1 Europe Opioid-Induced Constipation Market Size YoY Growth 2015-2026
9.2 Europe Opioid-Induced Constipation Market Facts & Figures by Country
9.2.1 Europe Opioid-Induced Constipation Sales by Country (2015-2026)
9.2.2 Europe Opioid-Induced Constipation Revenue by Country (2015-2026)
9.3 Europe Opioid-Induced Constipation Sales by Type
9.4 Europe Opioid-Induced Constipation Sales by Application
10 Latin America
10.1 Latin America Opioid-Induced Constipation Market Size YoY Growth 2015-2026
10.2 Latin America Opioid-Induced Constipation Market Facts & Figures by Country
10.2.1 Latin America Opioid-Induced Constipation Sales by Country (2015-2026)
10.2.2 Latin America Opioid-Induced Constipation Revenue by Country (2015-2026)
10.3 Latin America Opioid-Induced Constipation Sales by Type
10.4 Latin America Opioid-Induced Constipation Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Opioid-Induced Constipation Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Opioid-Induced Constipation Market Facts & Figures by Country
11.2.1 Middle East and Africa Opioid-Induced Constipation Sales by Country (2015-2026)
11.2.2 Middle East and Africa Opioid-Induced Constipation Revenue by Country (2015-2026)
11.3 Middle East and Africa Opioid-Induced Constipation Sales by Type
11.4 Middle East and Africa Opioid-Induced Constipation Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Opioid-Induced Constipation Supply Chain Analysis
12.2 Opioid-Induced Constipation Key Raw Materials and Upstream Suppliers
12.3 Opioid-Induced Constipation Clients Analysis
12.4 Opioid-Induced Constipation Sales Channel and Sales Model Analysis
12.4.1 Opioid-Induced Constipation Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Opioid-Induced Constipation Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Opioid-Induced Constipation Distributors
13 Market Dynamics
13.1 Opioid-Induced Constipation Market Drivers
13.2 Opioid-Induced Constipation Market Opportunities
13.3 Opioid-Induced Constipation Market Challenges
13.4 Opioid-Induced Constipation Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Opioid-Induced Constipation Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Major Manufacturers of Methylnaltrexone Bromide
Table 3. Major Manufacturers of Lubiprostone
Table 4. Major Manufacturers of Naloxegol
Table 5. Major Manufacturers of Others
Table 6. Global Opioid-Induced Constipation Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Opioid-Induced Constipation Market Size by Region (US$ Million): 2020 VS 2026
Table 8. Global Opioid-Induced Constipation Sales by Region (2015-2020) & (K Units)
Table 9. Global Opioid-Induced Constipation Sales Forecast by Region (2021-2026) & (K Units)
Table 10. Global Opioid-Induced Constipation Revenue by Region (2015-2020) & (US$ Million)
Table 11. Global Opioid-Induced Constipation Revenue Forecast by Region (2021-2026) & (US$ Million)
Table 12. Global Opioid-Induced Constipation Sales by Manufacturer (2015-2020) & (K Units)
Table 13. Global Opioid-Induced Constipation Sales Share by Manufacturer (2015-2020)
Table 14. Opioid-Induced Constipation Revenue by Manufacturer (2015-2020) & (US$ Million)
Table 15. Opioid-Induced Constipation Revenue Share by Manufacturer (2015-2020)
Table 16. Key Manufacturers Opioid-Induced Constipation Price (2015-2020) & (USD/Unit)
Table 17. Ranking of Global Top Opioid-Induced Constipation Manufacturers by Revenue (US$ Million) in 2019
Table 18. Global Opioid-Induced Constipation Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)
Table 19. Global Opioid-Induced Constipation by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid-Induced Constipation as of 2019)
Table 20. Opioid-Induced Constipation Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Opioid-Induced Constipation Product Type
Table 22. Date of International Manufacturers Enter into Opioid-Induced Constipation Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Takeda Pharmaceuticals Corporation Information
Table 25. Takeda Pharmaceuticals Description and Business Overview
Table 26. Takeda Pharmaceuticals Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 27. Takeda Pharmaceuticals Opioid-Induced Constipation Product
Table 28. Takeda Pharmaceuticals Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 29. Takeda Pharmaceuticals Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 30. Takeda Pharmaceuticals Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 31. Takeda Pharmaceuticals Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Sales Channel
Table 32. Takeda Pharmaceuticals Recent Development
Table 33. Bayer Corporation Information
Table 34. Bayer Description and Business Overview
Table 35. Bayer Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 36. Bayer Opioid-Induced Constipation Product
Table 37. Bayer Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 38. Bayer Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 39. Bayer Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 40. Bayer Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Sales Channel
Table 41. Bayer Recent Development
Table 42. Sanofi Corporation Information
Table 43. Sanofi Description and Business Overview
Table 44. Sanofi Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 45. Sanofi Opioid-Induced Constipation Product
Table 46. Sanofi Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 47. Sanofi Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 48. Sanofi Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 49. Sanofi Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Sales Channel
Table 50. Sanofi Recent Development
Table 51. Mallinckrodt Corporation Information
Table 52. Mallinckrodt Description and Business Overview
Table 53. Mallinckrodt Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 54. Mallinckrodt Opioid-Induced Constipation Product
Table 55. Mallinckrodt Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 56. Mallinckrodt Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 57. Mallinckrodt Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 58. Mallinckrodt Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Sales Channel
Table 59. Mallinckrodt Recent Development
Table 60. Salix (Bausch Health) Corporation Information
Table 61. Salix (Bausch Health) Description and Business Overview
Table 62. Salix (Bausch Health) Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. Salix (Bausch Health) Opioid-Induced Constipation Product
Table 64. Salix (Bausch Health) Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 65. Salix (Bausch Health) Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 66. Salix (Bausch Health) Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 67. Salix (Bausch Health) Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Sales Channel
Table 68. Salix (Bausch Health) Recent Development
Table 69. AstraZeneca Corporation Information
Table 70. AstraZeneca Description and Business Overview
Table 71. AstraZeneca Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. AstraZeneca Opioid-Induced Constipation Product
Table 73. AstraZeneca Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 74. AstraZeneca Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 75. AstraZeneca Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 76. AstraZeneca Recent Development
Table 77. Progenics Pharmaceuticals Corporation Information
Table 78. Progenics Pharmaceuticals Description and Business Overview
Table 79. Progenics Pharmaceuticals Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Progenics Pharmaceuticals Opioid-Induced Constipation Product
Table 81. Progenics Pharmaceuticals Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 82. Progenics Pharmaceuticals Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 83. Progenics Pharmaceuticals Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 84. Progenics Pharmaceuticals Recent Development
Table 85. Purdue Pharm Corporation Information
Table 86. Purdue Pharm Description and Business Overview
Table 87. Purdue Pharm Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Purdue Pharm Opioid-Induced Constipation Product
Table 89. Purdue Pharm Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 90. Purdue Pharm Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 91. Purdue Pharm Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 92. Purdue Pharm Recent Development
Table 93. Nektar Therapeutics Corporation Information
Table 94. Nektar Therapeutics Description and Business Overview
Table 95. Nektar Therapeutics Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Nektar Therapeutics Opioid-Induced Constipation Product
Table 97. Nektar Therapeutics Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 98. Nektar Therapeutics Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 99. Nektar Therapeutics Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 100. Nektar Therapeutics Recent Development
Table 101. Daiichi Sankyo Corporation Information
Table 102. Daiichi Sankyo Description and Business Overview
Table 103. Daiichi Sankyo Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Daiichi Sankyo Opioid-Induced Constipation Product
Table 105. Daiichi Sankyo Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 106. Daiichi Sankyo Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 107. Daiichi Sankyo Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 108. Daiichi Sankyo Recent Development
Table 109. Prestige Corporation Information
Table 110. Prestige Description and Business Overview
Table 111. Prestige Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Prestige Opioid-Induced Constipation Product
Table 113. Prestige Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 114. Prestige Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 115. Prestige Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 116. Prestige Recent Development
Table 117. GSK Corporation Information
Table 118. GSK Description and Business Overview
Table 119. GSK Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. GSK Opioid-Induced Constipation Product
Table 121. GSK Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 122. GSK Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 123. GSK Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 124. GSK Recent Development
Table 125. Shionogi Corporation Information
Table 126. Shionogi Description and Business Overview
Table 127. Shionogi Opioid-Induced Constipation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Shionogi Opioid-Induced Constipation Product
Table 129. Shionogi Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Product
Table 130. Shionogi Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Application
Table 131. Shionogi Opioid-Induced Constipation Revenue (US$ Million) and Market Share by Geographic Area
Table 132. Shionogi Recent Development
Table 133. Global Opioid-Induced Constipation Sales by Type (2015-2020) & (K Units)
Table 134. Global Opioid-Induced Constipation Sales Forecast by Type (2021-2026) & (K Units)
Table 135. Global Opioid-Induced Constipation Revenue by Type (2015-2020) & (US$ Million)
Table 136. Global Opioid-Induced Constipation Revenue Forecast by Type (2021-2026) & (US$ Million)
Table 137. Global Opioid-Induced Constipation Sales by Application (2015-2020) & (K Units)
Table 138. Global Opioid-Induced Constipation Sales Forecast by Application (2021-2026) & (K Units)
Table 139. Global Opioid-Induced Constipation Revenue by Application (2015-2020) & (US$ Million)
Table 140. Global Opioid-Induced Constipation Revenue Forecast by Application (2021-2026) & (US$ Million)
Table 141. North America Opioid-Induced Constipation Sales by Country (2015-2020) & (K Units)
Table 142. North America Opioid-Induced Constipation Sales by Country (2021-2026) & (K Units)
Table 143. North America Opioid-Induced Constipation Revenue by Country (2015-2020) & (US$ Million)
Table 144. North America Opioid-Induced Constipation Revenue by Country (2021-2026) & (US$ Million)
Table 145. North America Opioid-Induced Constipation Sales by Type (2015-2020) & (K Units)
Table 146. North America Opioid-Induced Constipation Sales by Application (2015-2020) & (K Units)
Table 147. Asia-Pacific Opioid-Induced Constipation Sales by Region (2015-2020) & (K Units)
Table 148. Asia-Pacific Opioid-Induced Constipation Sales by Region (2021-2026) & (K Units)
Table 149. Asia-Pacific Opioid-Induced Constipation Revenue by Region (2015-2026) & (US$ Million)
Table 150. Asia-Pacific Opioid-Induced Constipation Revenue by Region (2021-2026) & (US$ Million)
Table 151. Asia-Pacific Opioid-Induced Constipation Sales by Type (2015-2020) & (K Units)
Table 152. Asia-Pacific Opioid-Induced Constipation Sales by Application (2015-2020) & (K Units)
Table 153. Europe Opioid-Induced Constipation Sales by Country (2015-2020) & (K Units)
Table 154. Europe Opioid-Induced Constipation Sales by Country (2021-2026) & (K Units)
Table 155. Europe Opioid-Induced Constipation Revenue by Country (2015-2020) & (US$ Million)
Table 156. Europe Opioid-Induced Constipation Revenue by Country (2021-2026) & (US$ Million)
Table 157. Europe Opioid-Induced Constipation Sales by Type (2015-2020) & (K Units)
Table 158. Europe Opioid-Induced Constipation Sales by Application (2015-2020) & (K Units)
Table 159. Latin America Opioid-Induced Constipation Sales by Country (2015-2020) & (K Units)
Table 160. Latin America Opioid-Induced Constipation Sales by Country (2021-2026) & (K Units)
Table 161. Latin America Opioid-Induced Constipation Revenue by Country (2015-2020) & (US$ Million)
Table 162. Latin America Opioid-Induced Constipation Revenue by Country (2021-2026) & (US$ Million)
Table 163. Latin America Opioid-Induced Constipation Sales by Type (2015-2020) & (K Units)
Table 164. Latin America Opioid-Induced Constipation Sales by Application (2015-2020) & (K Units)
Table 165. Middle East and Africa Opioid-Induced Constipation Sales by Country (2015-2020) & (K Units)
Table 166. Middle East and Africa Opioid-Induced Constipation Sales by Country (2021-2026) & (K Units)
Table 167. Middle East and Africa Opioid-Induced Constipation Revenue by Country (2015-2020) & (US$ Million)
Table 168. Middle East and Africa Opioid-Induced Constipation Revenue by Country (2021-2026) & (US$ Million)
Table 169. Middle East and Africa Opioid-Induced Constipation Sales by Type (2015-2020) & (K Units)
Table 170. Middle East and Africa Opioid-Induced Constipation Sales by Application (2015-2020) & (K Units)
Table 171. Opioid-Induced Constipation Key Raw Materials, Industry Status and Trend
Table 172. Opioid-Induced Constipation Key Raw Materials and Upstream Suppliers
Table 173. Opioid-Induced Constipation Clients Status and Trend
Table 174. Opioid-Induced Constipation Typical Clients
Table 175. Opioid-Induced Constipation Distributors
Table 176. Key Drivers: Impact Analysis (2021-2026)
Table 177. Opioid-Induced Constipation Market Drivers
Table 178. Opioid-Induced Constipation Market Opportunities
Table 179. Opioid-Induced Constipation Market Challenges
Table 180. Opioid-Induced Constipation Market Restraints
Table 181. Opioid-Induced Constipation Porter's Five Forces Analysis
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioid-Induced Constipation Product Picture
Figure 2. Global Opioid-Induced Constipation Sales Market Share by Type in 2020 & 2026
Figure 3. Methylnaltrexone Bromide Product Picture
Figure 4. Lubiprostone Product Picture
Figure 5. Naloxegol Product Picture
Figure 6. Others Product Picture
Figure 7. Global Opioid-Induced Constipation Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital Examples
Figure 9. Pharmacy Examples
Figure 10. Opioid-Induced Constipation Report Years Considered
Figure 11. Global Opioid-Induced Constipation Market Size, (US$ Million), 2015 VS 2020 VS 2026
Figure 12. Global Opioid-Induced Constipation Market Size 2015-2026 (US$ Million)
Figure 13. Global Opioid-Induced Constipation Sales 2015-2026 (K Units)
Figure 14. Global Opioid-Induced Constipation Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Opioid-Induced Constipation Sales Market Share Forecast by Region (2015-2026)
Figure 16. Global Opioid-Induced Constipation Revenue Market Share by Region (2015-2026)
Figure 17. Global Opioid-Induced Constipation Sales Share by Manufacturer in 2019
Figure 18. Opioid-Induced Constipation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Opioid-Induced Constipat

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs